In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel.

Authors:
Roberts O; Kinvig H; Owen A; Lamorde M; Siccardi M and 1 more

Journal:
HIV Med

Publication Year: 2021

DOI:
10.1111/hiv.13136

PMCID:
PMC9363158

PMID:
34328253

View on PubMed View on PMC View Publisher
Journal Information

Full Title: HIV Med

Abbreviation: HIV Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HB…
Gizaw A; King WC; Hinerman AS and 12 more (2022) - Transparency Score: 4/6
Comorbidities in women living with HIV: A systematic review.
Raffe S; Sabin C; Gilleece Y and 2 more (2022) - Transparency Score: 3/6
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A quali…
Courvoisier N; Storari C; Lesage S and 5 more (2022) - Transparency Score: 2/6
High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-lin…
Anderson K; Pietersen E; Shepherd BE and 5 more (2022) - Transparency Score: 3/6
Impact of COVID-19 on HIV late diagnosis in a specialized German centre.
van Bremen K; Monin M; Schlabe S and 6 more (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Funding information This study was funded by the National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development [Grant Number: 1R01HD085887 (Scarsi)]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025